re: Ann: Arrowhead BID Updated Research Repor... Maybe i read thing's and misinterpret them in the following paragraph I read it as saying the deal is done with Sri Lanka, Is this just an over site/error by the publisher or have i read it wrong??
sentence thats starts with ."While Metamizer revenue"
Key variable analysis for valuation
In a complete analysis, MediVac?s revenue forecast is mostly sensitive to its key products viz. MetaMizer
240 SSS, SunnyWipes and Ozonator NG-1000 and with respect to their market, market share and
margins. We expect revenues to increase through the sale of MetaMiaer 240 SSS and SunnyWipes
products. While MetamiZer revenue generation will be supported by its recent Sri Lankan export order,
the recent TGA approval for the SunnyWipes Hand Gel and SunnyWipes General Virucidal and
Antimicrobial Workplace Wipes will support SunnyWipes sales revenues going forward.
- Forums
- ASX - By Stock
- MDV
- Ann: Arrowhead BID Updated Research Report Availa
Ann: Arrowhead BID Updated Research Report Availa, page-7
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MDV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online